search
Back to results

Effect of Botox and Vibration on Bone in Children With Cerebral Palsy

Primary Purpose

Cerebral Palsy, Muscle Spasticity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Low-magnitude vibration
Botox
Sponsored by
University of Delaware
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cerebral Palsy focused on measuring Botox, Muscle strength

Eligibility Criteria

2 Years - 12 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion (Children with CP):

  1. Have spastic CP
  2. Between 2-12 years of age
  3. Recommended for Botox treatment by their physician as part of their clinical care. Those who accept Botox treatment and those who do not accept Botox treatment are both eligible for the study.
  4. A score of 1-4 on the gross motor function classification scale (GMFCS)

Exclusion (Children with CP):

  1. Botox treatment in the lower extremities within the last year
  2. Metal rods in both legs

Inclusion (Typically developing children):

  1. Between 2 and 12 years of age.
  2. Match a child with CP for sex, age and race.

Exclusion(Typically developing children):

  1. Neurological disorder
  2. Surgery in the lower extremities within the last year.
  3. Chronic medication use

Sites / Locations

  • University of Delaware
  • Alfred I. duPont Hospital for Children, Nemours

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

No Intervention

No Intervention

Arm Label

Botox plus low-magnitude vibration

Botox

Cerebral palsy control

Typically developing control

Arm Description

Cerebral palsy and Botox + vibration

Cerebral palsy and Botox

Cerebral palsy without treatment

Typically developing

Outcomes

Primary Outcome Measures

Bone Structure
Change in cortical bone volume of the middle third of the tibia from baseline to 6 months, as measured by MRI.

Secondary Outcome Measures

Muscle Volume
Change in muscle volume of the midleg from baseline to 6 months, as measured by MRI
Bone Mass
Change in bone mineral content in the distal femur from baseline to 6 months, as measured by dual-energy X-ray absorptiometry (DXA)

Full Information

First Posted
February 27, 2013
Last Updated
February 20, 2018
Sponsor
University of Delaware
Collaborators
Alfred I. duPont Hospital for Children, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
search

1. Study Identification

Unique Protocol Identification Number
NCT01803464
Brief Title
Effect of Botox and Vibration on Bone in Children With Cerebral Palsy
Official Title
Effect of Botox and Vibration on Bone in Children With Cerebral Palsy
Study Type
Interventional

2. Study Status

Record Verification Date
February 2018
Overall Recruitment Status
Completed
Study Start Date
March 2012 (undefined)
Primary Completion Date
February 2015 (Actual)
Study Completion Date
February 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Delaware
Collaborators
Alfred I. duPont Hospital for Children, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Cerebral palsy (CP) is a neuromuscular disorder that affects approximately 800,000 individuals in the U.S. An estimated 70-80% of these individuals have spasticity which affects ambulation and requires management. Therefore, the treatment of spasticity is a primary goal of interventions for children with CP. One treatment widely used to reduce spasticity is Botox because of its ability to temporarily paralyze a muscle. However, no studies have determined the effect of Botox treatment on bone in humans. Also, a low magnitude vibration treatment has been shown to improve bone structure in the lower extremity bones of children with CP. The aims of this study are: 1) to determine the effect of Botox treatment in conjunction with a daily vibration treatment on bone mass and bone structure in children with spastic CP, and 2) to identify the mechanism that underlies the effect of Botox and vibration on bone.
Detailed Description
The investigators have been working with children diagnosed with cerebral palsy (CP) for the past 10 years. The investigators have found that bone structure is markedly underdeveloped and bone strength is severely compromised in children with CP. Also, an increased fracture rate has been observed in the lower extremity bones of children with CP. There is evidence that Botox, which is used to treat spasticity in CP, can improve motor function; however the effect of Botox on human bone is unknown. There is also evidence that low magnitude vibration treatment can improve bone mass and bone structure. The overall goal of this current research study is to investigate the effect and mechanism of action of Botox and vibration on bone in children with CP. The investigators will also examine the effect of Botox on muscle volume. A total of 36 participants will participate in this study. The investigators will assess bone structure and muscle volume using MRI. The investigators will assess bone mass using dual-energy X-ray absorptiometry (DXA).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cerebral Palsy, Muscle Spasticity
Keywords
Botox, Muscle strength

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
29 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Botox plus low-magnitude vibration
Arm Type
Experimental
Arm Description
Cerebral palsy and Botox + vibration
Arm Title
Botox
Arm Type
Experimental
Arm Description
Cerebral palsy and Botox
Arm Title
Cerebral palsy control
Arm Type
No Intervention
Arm Description
Cerebral palsy without treatment
Arm Title
Typically developing control
Arm Type
No Intervention
Arm Description
Typically developing
Intervention Type
Device
Intervention Name(s)
Low-magnitude vibration
Intervention Description
Children will receive a daily low-magnitude vibration treatment.
Intervention Type
Drug
Intervention Name(s)
Botox
Intervention Description
Children who are candidates to receive Botox as part of their standard of care.
Primary Outcome Measure Information:
Title
Bone Structure
Description
Change in cortical bone volume of the middle third of the tibia from baseline to 6 months, as measured by MRI.
Time Frame
baseline to 6 months
Secondary Outcome Measure Information:
Title
Muscle Volume
Description
Change in muscle volume of the midleg from baseline to 6 months, as measured by MRI
Time Frame
baseline to 6 months
Title
Bone Mass
Description
Change in bone mineral content in the distal femur from baseline to 6 months, as measured by dual-energy X-ray absorptiometry (DXA)
Time Frame
baseline to 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion (Children with CP): Have spastic CP Between 2-12 years of age Recommended for Botox treatment by their physician as part of their clinical care. Those who accept Botox treatment and those who do not accept Botox treatment are both eligible for the study. A score of 1-4 on the gross motor function classification scale (GMFCS) Exclusion (Children with CP): Botox treatment in the lower extremities within the last year Metal rods in both legs Inclusion (Typically developing children): Between 2 and 12 years of age. Match a child with CP for sex, age and race. Exclusion(Typically developing children): Neurological disorder Surgery in the lower extremities within the last year. Chronic medication use
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christopher Modlesky, PhD
Organizational Affiliation
University of Delaware
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Freeman Miller, MD
Organizational Affiliation
Nemours/Alfred I duPont Hospital for Children
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Delaware
City
Newark
State/Province
Delaware
ZIP/Postal Code
19716
Country
United States
Facility Name
Alfred I. duPont Hospital for Children, Nemours
City
Wilmington
State/Province
Delaware
ZIP/Postal Code
19899
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
De-identified individual participant data for all primary and secondary outcome measures will be made available.
IPD Sharing Time Frame
Within 30 days of the request.
IPD Sharing Access Criteria
Data access requests will be reviewed by the PIs. Requestors will be required to sign a Data Access Agreement.
Citations:
PubMed Identifier
19111321
Citation
Johnson DL, Miller F, Subramanian P, Modlesky CM. Adipose tissue infiltration of skeletal muscle in children with cerebral palsy. J Pediatr. 2009 May;154(5):715-20. doi: 10.1016/j.jpeds.2008.10.046. Epub 2008 Dec 25.
Results Reference
background
PubMed Identifier
17962918
Citation
Modlesky CM, Subramanian P, Miller F. Underdeveloped trabecular bone microarchitecture is detected in children with cerebral palsy using high-resolution magnetic resonance imaging. Osteoporos Int. 2008 Feb;19(2):169-76. doi: 10.1007/s00198-007-0433-x. Epub 2007 Oct 26.
Results Reference
background
PubMed Identifier
11811566
Citation
Rubin C, Turner AS, Muller R, Mittra E, McLeod K, Lin W, Qin YX. Quantity and quality of trabecular bone in the femur are enhanced by a strongly anabolic, noninvasive mechanical intervention. J Bone Miner Res. 2002 Feb;17(2):349-57. doi: 10.1359/jbmr.2002.17.2.349.
Results Reference
background
PubMed Identifier
12572652
Citation
Judex S, Boyd S, Qin YX, Turner S, Ye K, Muller R, Rubin C. Adaptations of trabecular bone to low magnitude vibrations result in more uniform stress and strain under load. Ann Biomed Eng. 2003 Jan;31(1):12-20. doi: 10.1114/1.1535414.
Results Reference
background
PubMed Identifier
20864862
Citation
Wren TA, Lee DC, Hara R, Rethlefsen SA, Kay RM, Dorey FJ, Gilsanz V. Effect of high-frequency, low-magnitude vibration on bone and muscle in children with cerebral palsy. J Pediatr Orthop. 2010 Oct-Nov;30(7):732-8. doi: 10.1097/BPO.0b013e3181efbabc.
Results Reference
background
PubMed Identifier
15040823
Citation
Ward K, Alsop C, Caulton J, Rubin C, Adams J, Mughal Z. Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res. 2004 Mar;19(3):360-9. doi: 10.1359/JBMR.040129. Epub 2004 Jan 27.
Results Reference
background
PubMed Identifier
25199575
Citation
Modlesky CM, Whitney DG, Singh H, Barbe MF, Kirby JT, Miller F. Underdevelopment of trabecular bone microarchitecture in the distal femur of nonambulatory children with cerebral palsy becomes more pronounced with distance from the growth plate. Osteoporos Int. 2015 Feb;26(2):505-12. doi: 10.1007/s00198-014-2873-4. Epub 2014 Sep 9.
Results Reference
result
PubMed Identifier
24269277
Citation
Modlesky CM, Whitney DG, Carter PT, Allerton BM, Kirby JT, Miller F. The pattern of trabecular bone microarchitecture in the distal femur of typically developing children and its effect on processing of magnetic resonance images. Bone. 2014 Mar;60:1-7. doi: 10.1016/j.bone.2013.11.009. Epub 2013 Nov 20.
Results Reference
result
PubMed Identifier
26392035
Citation
Singh H, Whitney DG, Knight CA, Miller F, Manal K, Kolm P, Modlesky CM. Site-Specific Transmission of a Floor-Based, High-Frequency, Low-Magnitude Vibration Stimulus in Children With Spastic Cerebral Palsy. Arch Phys Med Rehabil. 2016 Feb;97(2):218-23. doi: 10.1016/j.apmr.2015.08.434. Epub 2015 Sep 21.
Results Reference
derived

Learn more about this trial

Effect of Botox and Vibration on Bone in Children With Cerebral Palsy

We'll reach out to this number within 24 hrs